evidence table

Moringa Cognition Randomized Trial Evidence Table

Structured evidence table for Moringa Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Moringa Cognition Randomized TrialCognitive disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, depression, and vascular dementia, are associated with dysregulation of neurotransmitter systems, including acetylcholine, dopamine, serotonin, glutamate, and γ-aminobutyric acid (GABA).4Rahman M (2026)Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
Moringa Cognition Randomized TrialCurrent pharmacological therapies may provide symptomatic relief; however, their clinical benefits are often limited and associated with adverse effects.4Rahman M (2026)Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
Moringa Cognition Randomized TrialPreclinical evidence and emerging clinical studies suggest that herbal bioactive compounds may exert neuroprotective effects through antioxidants, anti-inflammatory, and neurotransmitter-modulating mechanisms.4Rahman M (2026)Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
Moringa Cognition Randomized TrialThese disorders are increasingly recognized as multifactorial conditions involving oxidative stress, neuroinflammation, mitochondrial dysfunction, synaptic impairment, blood-brain barrier disruption, metabolic imbalance, and gut-brain axis dysregulation.4Rahman M (2026)Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
Moringa Cognition Randomized TrialResults The participants were divided into responders (improved cognitive function) and non-responders (no improvement) within each sex group.4Hatayama K (2025)Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
Moringa Cognition Randomized TrialResponders exhibited variations in intestinal bacteria belonging to specific taxa, including Agathobaculum , Anaerobutyricum , Blautia , Faecalibacterium , Parabacteroides , and Phascolarctobacterium , compared to non-responders, indicating that cognitive function may be improved by changes in specific intestinal bacteria with food intake.4Hatayama K (2025)Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
Moringa Cognition Randomized TrialConclusion Food intervention approaches targeting the intestinal microbiota could lead to innovative solutions for improving cognitive function in the elderly.4Hatayama K (2025)Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
Moringa Cognition Randomized TrialIntroduction The large number of elderly patients with dementia and mild cognitive impairment with cognitive decline in Japan has become a social problem.4Hatayama K (2025)Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
topicMoringa Cognition Randomized Trial
claimCognitive disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, depression, and vascular dementia, are associated with dysregulation of neurotransmitter systems, including acetylcholine, dopamine, serotonin, glutamate, and γ-aminobutyric acid (GABA).
evidence level4
citationRahman M (2026)
sourceHerbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
topicMoringa Cognition Randomized Trial
claimCurrent pharmacological therapies may provide symptomatic relief; however, their clinical benefits are often limited and associated with adverse effects.
evidence level4
citationRahman M (2026)
sourceHerbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
topicMoringa Cognition Randomized Trial
claimPreclinical evidence and emerging clinical studies suggest that herbal bioactive compounds may exert neuroprotective effects through antioxidants, anti-inflammatory, and neurotransmitter-modulating mechanisms.
evidence level4
citationRahman M (2026)
sourceHerbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
topicMoringa Cognition Randomized Trial
claimThese disorders are increasingly recognized as multifactorial conditions involving oxidative stress, neuroinflammation, mitochondrial dysfunction, synaptic impairment, blood-brain barrier disruption, metabolic imbalance, and gut-brain axis dysregulation.
evidence level4
citationRahman M (2026)
sourceHerbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
topicMoringa Cognition Randomized Trial
claimResults The participants were divided into responders (improved cognitive function) and non-responders (no improvement) within each sex group.
evidence level4
citationHatayama K (2025)
sourceEffect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
topicMoringa Cognition Randomized Trial
claimResponders exhibited variations in intestinal bacteria belonging to specific taxa, including Agathobaculum , Anaerobutyricum , Blautia , Faecalibacterium , Parabacteroides , and Phascolarctobacterium , compared to non-responders, indicating that cognitive function may be improved by changes in specific intestinal bacteria with food intake.
evidence level4
citationHatayama K (2025)
sourceEffect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
topicMoringa Cognition Randomized Trial
claimConclusion Food intervention approaches targeting the intestinal microbiota could lead to innovative solutions for improving cognitive function in the elderly.
evidence level4
citationHatayama K (2025)
sourceEffect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.
topicMoringa Cognition Randomized Trial
claimIntroduction The large number of elderly patients with dementia and mild cognitive impairment with cognitive decline in Japan has become a social problem.
evidence level4
citationHatayama K (2025)
sourceEffect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.

Learn next

Related evidence and supplement guides

GuideMoringa Cognition Randomized Trial: What the Evidence SaysMoringa Cognition Randomized Trial has 2 source documents in the current Migaku evidence databas...GuideN Acetyl Cysteine Cognition Randomized Trial: What the Evidence SaysN Acetyl Cysteine Cognition Randomized Trial has 2 source documents in the current Migaku eviden...GuideSage Cognition Randomized Trial: What the Evidence SaysSage Cognition Randomized Trial has 2 source documents in the current Migaku evidence database....GuideN-acetylcysteine Cognition Randomized Trial: What the Evidence SaysN-acetylcysteine Cognition Randomized Trial has 2 source documents in the current Migaku evidenc...RankingBest Nootropics for Focus & Attention: 2026 Clinical Evidence ReviewWe separate the clinical evidence from the marketing hype, ranking the most effective brain supp...RankingBest Supplements for Anxiety: Evidence-Based Rankings 2026Anxiety supplements with genuine clinical evidence include ashwagandha (strongest for chronic an...RankingBest Nootropics for Focus & Cognition: 2026 Clinical RankingsAn examination of cognitive enhancers designed to increase neurotransmitter activity, improve sy...AnswerDoes Moringa Cognition Randomized Trial work?Moringa Cognition Randomized Trial has evidence relevant to strength of evidence and what the st...

Source documents

  1. Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.
  2. Effect of a specific food intervention with Tamogitake mushroom, Moringa leaves, or rice bran on intestinal microbiota and cognitive function in elderly Japanese.